-transparent.png){kind=logo}
In a double-blind cross-over trial in rheumatoid arthritis, no difference was found between ketoprofen and phenylbutazone with regard to clinical efficacy at the dosages used. There was a higher incidence of side-effects reported during treatment with phenylbutazone.
Related Publications
O A Sydnes, and
H K Brath, and
L B Haerum, and
S Straume
January 1976,
Rheumatology and rehabilitation,
O A Sydnes, and
H K Brath, and
L B Haerum, and
S Straume
February 1982,
Ryumachi. [Rheumatism],
O A Sydnes, and
H K Brath, and
L B Haerum, and
S Straume
January 1973,
Scandinavian journal of rheumatology. Supplement,
O A Sydnes, and
H K Brath, and
L B Haerum, and
S Straume
May 1979,
Rheumatology and rehabilitation,
O A Sydnes, and
H K Brath, and
L B Haerum, and
S Straume
January 1977,
The Journal of rheumatology,
O A Sydnes, and
H K Brath, and
L B Haerum, and
S Straume
May 1975,
Rheumatology and rehabilitation,
O A Sydnes, and
H K Brath, and
L B Haerum, and
S Straume
January 1983,
International journal of tissue reactions,
O A Sydnes, and
H K Brath, and
L B Haerum, and
S Straume
May 1980,
British journal of clinical pharmacology,
O A Sydnes, and
H K Brath, and
L B Haerum, and
S Straume
July 1974,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
O A Sydnes, and
H K Brath, and
L B Haerum, and
S Straume
January 1978,
The Journal of international medical research,
